DALLAS, July 10, 2007 (PRIME NEWSWIRE) -- John Pentony, publisher of StockGuru.com, announced today that the web site is continuing Profile Coverage of Lantis Laser Inc. (Pink Sheets:LLSR). Lantis is focused on developing its exclusive OCT Dental Imaging System for use in general dentistry under license from Lawrence Livermore National Laboratory and LightLab Imaging.
Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. The Company plans to launch the OCT Dental Imaging System in the third quarter of 2008 as its first product. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory and LightLab Imaging. OCT was invented in the early 1990's at the Massachusetts Institute of Technology and is currently being commercialized by Carl Zeiss Meditec, Inc. in ophthalmology and by LightLab Imaging for cardiovascular imaging. In a press release on November 8th, 2006 Carl Zeiss Meditec AG announced the sale of its 6000th OCT Stratus System, initially introduced in 2002. At an approximate retail price of $65,000 per system, this generated almost $400 million in sales. LightLab Imaging is commercializing OCT for cardiovascular imaging with systems currently being sold in Europe, and entry in the near future into the U.S. and Japanese markets.
To view the StockGuru.com profile for Lantis Laser Inc., please visit http://www.stockguru.com/profiles/llsr
About StockGuru.com
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visithttp://www.stockguru.com/stocks.htm
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact John Pentony at (469) 252-3031 or email publisher@stockguru.com. Our services include our Morning, Midday, and After The Bell news releases. Additionally, we profile publicly traded companies on our web site, we do interviews with CEOs or other key executives on our web site, and we have our financial writers cover our companies.
Certain statements in this press release, including statements regarding the anticipated development and expansion of Lantis' business, and the intent, belief or current expectations of Lantis, its directors or its officers, are forward-looking statements. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.
Disclosure: Pentony Enterprises LLC was compensated $27,000 and 70,000 restricted shares directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. Pentony Enterprises no longer holds shares.